Technologist-Based Implementation of Total Metabolic Tumor Volume into Clinical Practice

J Nucl Med Technol. 2023 Mar;51(1):57-59. doi: 10.2967/jnmt.122.264714. Epub 2022 Nov 9.

Abstract

Metabolic tumor volume (MTV) is defined as the total metabolically active tumor volume seen on 18F-FDG PET/CT examinations. Calculating MTV is often time-consuming, requiring a high degree of manual input. In this study, the MTV calculations of a board-certified nuclear radiologist were compared with those of 2 nuclear medicine technologists. As part of the technologists' educational program, after their classroom time they were trained by the radiologist for 30 min. The technologists calculated MTV within 7.5% of the radiologist's calculations in a set of patients who had diffuse large B-cell lymphoma and were undergoing initial staging 18F-FDG PET/CT. These findings suggest that nuclear medicine technologists may help accelerate implementation of MTV into clinical practice with favorable accuracy, possibly as an initial step followed by validation by the interpreting physician. The aim of this study was to explore whether efficiency is improved by integrating nuclear medicine technologists into a semiautomated workflow to calculate total MTV.

Keywords: MTV; PET/CT; oncology; quality assurance; tumor segmentation.

MeSH terms

  • Fluorodeoxyglucose F18
  • Humans
  • Neoplasms*
  • Positron Emission Tomography Computed Tomography*
  • Positron-Emission Tomography
  • Prognosis
  • Radiopharmaceuticals
  • Retrospective Studies
  • Tumor Burden

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals